these choices ultimately influence pivotal patient outcomes such as relief of jaundice, durable decompression, infection risk, and overall survival?
In this issue of Digestive Diseases and Sciences, Cassani and colleagues [2] compared the overall survival of patients with CCA based upon the clinical success of biliary decompression. Moreover, various secondary outcomes of endoscopic retrograde cholangiopancreatography (ERCP)-directed biliary drainage are also presented in this large, retrospective experience from a referral cancer center. Cassani et al. included 199 subjects with obstructing CCA referred for ERCP over an extensive 17-year timeframe. This cohort underwent 504 ERCP procedures, conducted with methodology typical for an academic interventional endoscopy center. At baseline, patients included are characteristic of CCA, with a predominance of hilar tumors (85%). Most patients had previously undergone ERCP with plastic stent placement at a referring institution (52.8%); the technical success rate of the procedures was comparable with that of an expert center (98.2%).
The most striking observation made by Cassani et al. is that patients who underwent clinically successful biliary decompression had substantially prolonged overall survival (OS) compared with those in which decompression was not achievable (15.2 vs. 4.8 months). Although this is superficially unsurprising, there is little contemporary literature that clearly delineates this salient point. Though this distinction may reflect a fundamental difference in disease prognosis between groups irrespective of the intervention, it nonetheless underscores the potential importance of providing adequate relief of jaundice whenever possible. Resolution of jaundice was also observed more frequently in patients who underwent successful bilateral biliary stent placement than in those who underwent unilateral intervention. This finding, in keeping with published data [3, 4] , supports the concept that there is likely benefit in maximizing preserved liver volume via providing adequate drainage. One potential major risk of intended bilateral drainage appears to be an (Table 2 : supplement). This choice is highly individualized in the absence of discrete clinical trial data and is subject to significant unmeasured bias. Furthermore, since placement of a SEMS across the hepatic hilum is irreversible, its use must be thoughtfully considered. Remediation of one or more occluded hilar SEMS can represent a highly unsatisfying endoscopic dilemma, frequently requiring percutaneous hepatic biliary drainage (PTBD). Analyses which strongly favor SEMS use [6] usually rely on designs formulated to measure the number rather than the complexity of re-interventions, and may not capture the totality of interventions such as unwanted external drainage that often negatively impacts the quality of life in patients with terminal cancer.
The optimal management strategy for malignant biliary obstruction secondary to cholangiocarcinoma remains a subject of vigorous debate. Although the experience presented here by Cassani et al. is limited by its retrospective design, the data presented underscore several fundamental principles that are important to endoscopists caring for patients with this difficult disease. In the palliative setting, the impact of successful biliary decompression cannot be overstated. Relief of jaundice is of major significance to patients, as well as to medical and radiation oncologists, whose subsequent care may be markedly hampered by a failure to normalize serum bilirubin. Furthermore, maximizing the volume of successfully decompressed liver may have a meaningful impact on overall survival, independent of how that goal is achieved. Segments that remain undrained following ERCP likely increase the risk of cholangitis if injected, and should be avoided when possible.
Despite considerable interest, the optimal timing and precise contributions of plastic stents, PTBD, SEMS, and their interaction with emergent endoscopic local therapies for CCA, including radiofrequency ablation and photodynamic therapy, remain unsettled. Further randomized controlled data investigating each of these questions are sorely needed, but with rare exceptions [7] , are unlikely to be forthcoming.
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